Valproic acid increases CAR T cell cytotoxicity against acute myeloid leukemia
The treatment of B cell malignancies has dramatically changed with the introduction of immunotherapy, especially chimeric antigen receptor T (CAR-T) cell therapy. However, only limited efficacy is observed in acute myeloid leukaemia (AML). In the study, We detected CD123 and CLL-1 expression on leuk...
Main Authors: | Ting Yang, Jingjing Wen, Yanxin Chen, Jiajie Yang, Chunye Dai, Shenjie Yu, Wenting Zhong, Lilin Liu, Chengguanng He, Wenmin Zhang, Lingfeng Liu, Jianda Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-07-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/7/e006857.full |
Similar Items
-
Myeloid leukemia-derived galectin-1 downregulates CAR expression to hinder cytotoxicity of CAR T cells
by: Chuo Li, et al.
Published: (2024-01-01) -
Demethylating therapy increases cytotoxicity of CD44v6 CAR-T cells against acute myeloid leukemia
by: Ling Tang, et al.
Published: (2023-04-01) -
Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy
by: Yujie Liu, et al.
Published: (2024-03-01) -
Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances
by: Jile Liu, et al.
Published: (2023-05-01) -
CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them
by: Jolien Vanhooren, et al.
Published: (2023-09-01)